Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study

INTRODUCTION: Prolonged glucocorticoid use may increase the risk of adverse safety outcomes, including cardiovascular events. The European League Against Rheumatism and the Canadian Rheumatology Association advise tapering glucocorticoid dose as rapidly as clinically feasible. There is a paucity of...

Descripción completa

Detalles Bibliográficos
Autores principales: Alten, Rieke, Nüßlein, Hubert, Galeazzi, Mauro, Lorenz, Hanns-Martin, Nurmohamed, Michael T, Bensen, William G, Burmester, Gerd R, Peter, Hans-Hartmut, Pavelka, Karel, Chartier, Mélanie, Poncet, Coralie, Rauch, Christiane, Elbez, Yedid, Le Bars, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762207/
https://www.ncbi.nlm.nih.gov/pubmed/26925253
http://dx.doi.org/10.1136/rmdopen-2015-000228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762207/
https://www.ncbi.nlm.nih.gov/pubmed/26925253
http://dx.doi.org/10.1136/rmdopen-2015-000228

Ejemplares similares